Showing 1 - 6 results of 6 for search '"фактор Виллебрандта"', query time: 0.43s Refine Results
  1. 1
    Academic Journal

    Source: Eurasian Journal of Academic Research; Vol. 5 No. 11 (2025): Eurasian Journal of Academic Research; 35-42 ; Евразийский журнал академических исследований; Том 5 № 11 (2025): Евразийский журнал академических исследований; 35-42 ; Yevrosiyo ilmiy tadqiqotlar jurnali; Jild 5 Nomeri 11 (2025): Евразийский журнал академических исследований; 35-42 ; 2181-2020

    File Description: application/pdf

  2. 2
    Academic Journal

    Source: Journal Infectology; Том 4, № 4 (2012); 46-51 ; Журнал инфектологии; Том 4, № 4 (2012); 46-51 ; 2072-6732 ; 10.22625/2072-6732-2012-4-4

    File Description: application/pdf

    Relation: https://journal.niidi.ru/jofin/article/view/132/127; Giron-Gonzalez, J.A. Serial analysis of serum and ascitic fluid levels of soluble adhesion molecules and chemokines in patients with spontaneous bacterial peritonitis / J.A.Giron- Gonzalez [et al.] // Clin. Exp. Immunol. – 2001. – V. 123, № 1. – P. 56–61.; Thomson, A.W. Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes / A.W. Thomson [et al.] // Clin. Exp. Immunol. – 1994. – V. 95, № 1. – P. 83–90.; Tortorella, C. sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology / C. Tortorella [et al.] // Immunopharmacol Immunotoxicol. – 2000. – V. 22, № 1. – P. 19–33.; de Caestecker, J.S. Bile acid therapy and markers of immune-mediated damage in primary biliary cirrhosis / J.S. de Caestecker // Eur. J. Gastroenterol. Hepatol. – 1997. – V. 9, № 2. – P. 145–147.; Granot, E. Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients / E. Granot, D. Shouval, Y. Ashur // Mediators Inflamm. – 2001. – V. 10, № 5. – P. 253–258.; Marui, A. Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in liver disease, and their changes by treatment with interferon / A. Marui [et al.] // J. Int. Med. Res. – 1996. – V. 24, № 3. – P. 258–265.; Kukla, M. sPECAM-1 and sVCAM-1: Role in Pathogenesis and Diagnosis of Chronic Hepatitis C and Association with Response to Antiviral Therapy / M. Kukla [et al.] // Therap. Adv. Gastroenterol. – 2009. – V. 2, № 2. – P. 79–90.; Петрищев, Н.Н. Типовые формы дисфункции эндотелия / Н.Н. Петрищев [и др.] // Клин. лаб. консилиум. – 2007. – № 18. – С. 31–35.; Ley, K. VCAM–1 is critical in atherosclerosis / K. Ley, Y. Huo // J. Clin. Invest. – 2001. – № 107 (10). – P. 1209–1210.; Blann, A.D. Von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease /A.D. Blann // J. Reumatol. – 1993. – № 20. – P. 1469–1471.; Булатова, И.А. Функциональное состояние эндотелия при хроническом гепатите С / И.А. Булатова, В.В. Щёкотов, А.П. Щёкотова // РЖГГК. – 2009. – Т. 3. – С. 42–46.; Kulwas, A. Von Willebrand factor and thrombomodulin as markers of endothelial cell functions in children with chronic viral hepatitis / A. Kulwas [et al.] // Med. Wieku Rozwoj. – 2004. – V. 8, № 1. – P. 107–114.; Hui, J. Insulin resistance is associated with chronic hepatitis C and fibrosis progression / J. Hui [et al.] // Gastroenterology. – 2003. – V. 125, № 6. – P. 1695–1704.; D’Sousa, R. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy / R. D’Sousa, A. Sabin, G. R. Foster // Am. J. Gastroenterol. – 2005. – V. 100. – P. 1509–1515.; Cersosimo, E. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases / E. Cersosimo, R.A. DeFronzo // Diabetes Metab Res Rev. – 2006. – V. 22, № 6. – P. 423–436.; Hsueh, W.A. Insulin resistance and the endothelium /W.A. Hsueh, C.J. Lyon, M.J. Quiñones // Am, J, Med. –2004. – V. 117, № 2. – P. 109–117.; Bruno, C.M. Circulating adhesion molecules in patients with virus-related chronic diseases of the liver / C.M. Bruno [et al.] // World J. Gastroenterol. – 2005. – V. 11, № 29. – P. 4566–4569.; Lo Iacono, O. Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha / O. Lo Iacono [et al.] // Aliment Pharmacol Ther. – 1998. – V. 12, № 11. – P. 1091–1099.; Fukuda, Y. Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in asymptomatic carriers of hepatitis C virus / Y. Fukuda [et al.] // J. Int. Med. Res. – 1998. – V. 26, № 6. – P. 313–318.; La Mura, V. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension /V. La Mura [et al.] // Gut. – 2011. – V. 60, № 8. – P. 1133– 1138.; Ferlitsch, M. Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis / M. Ferlitsch [et al.] // Hepatology. – 2012. – V. 56, № 4. – P. 1439–1447.; https://journal.niidi.ru/jofin/article/view/132

  3. 3
  4. 4
  5. 5
  6. 6